.svg){kind=small}
Feb-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the competitive cannabis market of California, Trilogy 710 has shown a notable performance within the concentrates category over the recent months. Beginning in November 2023, the brand was ranked 28th, which is a solid position considering the vast number of competitors. Impressively, in December 2023, Trilogy 710 surged to the 19th rank, showcasing a significant increase in its market presence and consumer preference, as evidenced by a substantial rise in sales from $143,101 in November to $220,994 in December. However, the following months saw a slight fluctuation in its ranking, moving down to 26th in January 2024 and then improving to 22nd in February 2024. This rollercoaster movement in rankings, despite a consistent increase in sales, highlights the dynamic nature of consumer preferences and competitive pressures in the concentrates sector of California's cannabis market.
While Trilogy 710’s journey through the ranks demonstrates its resilience and growing appeal among consumers, the inability to consistently maintain or improve its position month-over-month suggests challenges in sustaining momentum in the face of stiff competition. Notably, the brand's fluctuating rankings, despite not dropping out of the top 30, indicate it has managed to maintain a significant presence in the market, which is commendable. However, the details behind these shifts in rankings—whether due to changes in consumer behavior, marketing strategies, or other external factors—are crucial for understanding the brand's performance trajectory fully. Trilogy 710's journey in the California market is a testament to its potential and the competitive dynamics of the cannabis industry, where brands continuously vie for consumer attention amidst evolving market conditions.
Competitive Landscape
In the competitive landscape of the concentrates category in California, Trilogy 710 has shown a notable fluctuation in its market position, as observed through recent monthly rankings. Initially not in the top 20 in November 2023, Trilogy 710 made a significant leap to the 19th position by December 2023, showcasing a remarkable increase in sales. However, the brand experienced a slight decline in rank to 26th in January 2024 before slightly recovering to 22nd in February 2024. This rollercoaster movement indicates a volatile market presence when compared to its competitors. For instance, Buddies and Humboldt Terp Council have shown more stability, with Buddies entering the top 20 in February 2024 and Humboldt Terp Council maintaining a consistent presence, albeit with slight fluctuations. Almora Farms and UP! also display a competitive edge with steadier rankings and sales trends. Trilogy 710's fluctuating rank and sales underscore the brand's challenges and opportunities in navigating the competitive dynamics of California's concentrate market.
Notable Products
In February 2024, Trilogy 710 saw Blue Nectar Live Rosin (1g) leading their sales with 691 units, marking it as the top-performing product within their Concentrates category. Following closely were Tahoe Cure Live Rosin (1g) and Pink Guava Live Rosin (1g), securing the second and third spots respectively, highlighting a strong preference for their Live Rosin line. Lemon Scone Live Rosin (1g), which was previously ranked second in January, dropped to the fourth position, indicating a shift in consumer preferences within the month. Banana Spritzer Live Rosin (1g) rounded out the top five, showcasing the overall dominance of the Live Rosin products in Trilogy 710's lineup. This ranking represents a fresh market snapshot, as there were no recorded sales for these products in the months leading up to February 2024, suggesting a significant and successful launch or restock event for Trilogy 710.
Top Selling Cannabis Brands
